<DOC>
	<DOC>NCT01960803</DOC>
	<brief_summary>The overall objective of this study is to determine the feasibility and tolerability of single dose Intraoperative Electron Radiation Treatment ("IOERT") as definitive therapy when administered at the time of breast conserving surgery for patients with early stage breast cancer.</brief_summary>
	<brief_title>Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)</brief_title>
	<detailed_description>Evaluate local and distant recurrence rates and cosmetic outcomes. Both clinical evaluation of cosmetic outcome by the Surgeon, and subjective impression of cosmetic outcome by the patient, are evaluated using questionnaire. Local recurrence is evaluated under the same imaging protocol used for Whole breast radiation.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Ductal, Breast</mesh_term>
	<criteria>Patient agrees to breast conservation therapy (segmental resection, partial mastectomy, and radiation therapy) as the treatment for their breast cancer Patient agrees to evaluation of the axilla with sentinel lymph node biopsy Postmenopausal women age &gt; 60, defined as women who have experienced no menstrual period in the past 6 months or more BRCA1 and 2 gene mutation negative, if tested. [genetic testing is NOT required based upon personal or family history] Unifocal (unicentric), invasive ductal carcinoma or favorable subtypes (mucinous, tubular, colloid) &lt; 2.0 cm in diameter, primary Tstage of T1 (AJCC criteria) Grade 1, 2, or 3 acceptable Associated LCIS is allowed Estrogen receptor (ER) status of positive Patient has clear margins &gt;2 mm on gross pathologic examination Patient is nodenegative, defined as N0 (i) or N0 (i+) Patient must be deemed functionally and mentally competent to understand and sign the informed consent Prior breast malignancy or other malignancy if metastatic, or with expected survival of &lt; 5 years Immunocompromised status Pregnancy Women with an active connective tissue disorder (i.e. scleroderma, lupus and others) Breast cancer that involves the skin or chest wall, locally advanced breast cancer Pure DCIS, all grades Invasive lobular carcinoma Evidence of lymphovascular invasion (LVI) Invasive carcinoma with extensive intraductal component (EIC) Neoadjuvant chemotherapy Patients with 1 or more positive lymph node determined during surgery with sentinel node and/or axillary dissection Someone who is not a candidate for breast conserving management, i.e., prior whole breast radiation therapy</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Stage I Breast Carcinoma</keyword>
</DOC>